Exosomes as Nanocarrier for Neurotherapy: Journey from Application to Challenges DOI
Yogita Ale, Nidhi Nainwal

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106312 - 106312

Published: Oct. 1, 2024

Language: Английский

Alginate/magnetic hydroxyapatite bio-nanocomposite hydrogel bead as a pH-responsive oral drug carrier for potential colon cancer therapy DOI Creative Commons
Rauf Foroutan, Ali Mohammadzadeh, Siamak Javanbakht

et al.

Results in Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 102177 - 102177

Published: March 1, 2025

Language: Английский

Citations

1
The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review DOI
Mohanna Khandan, Mohammad Amin Khazeei Tabari,

Seyed Mostafa Rahimi

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: March 28, 2025

Language: Английский

Citations

0
Exosomes in melanoma: Future potential for clinical theranostics DOI
Asmit Das, Swarup Sonar, Rajib Dhar

et al.

Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155950 - 155950

Published: March 1, 2025

Language: Английский

Citations

0
Exosome-based cancer vaccine: a cell-free approach DOI
Swarup Sonar, Asmit Das, Ketki Kalele

et al.

Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)

Published: April 24, 2025

Language: Английский

Citations

0
Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application DOI Creative Commons
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(11), P. 1282 - 1282

Published: Nov. 15, 2024

Milk-derived extracellular vesicles (mEVs) are emerging as promising therapeutic candidates due to their unique properties and versatile functions. These play a crucial role in immunomodulation by influencing macrophage differentiation cytokine production, potentially aiding the treatment of conditions such bone loss, fibrosis, cancer. mEVs also have capacity modulate gut microbiota composition, which may alleviate symptoms inflammatory bowel diseases promote intestinal barrier integrity. Their potential drug delivery vehicles is significant, enhancing stability, solubility, bioavailability anticancer agents while supporting wound healing reducing inflammation. Additionally, bovine exhibit anti-aging protect skin cells from UV damage. As vaccine platforms, offer advantages including biocompatibility, antigen protection, ability elicit robust immune responses through targeted specific cells. Despite these applications, challenges persist, complex roles cancer, effective loading, regulatory hurdles, need for standardized production methods. Achieving high targeting specificity understanding long-term effects mEV-based therapies essential clinical translation. Ongoing research aims optimize mEV methods, enhance capabilities, conduct rigorous preclinical studies. By addressing challenges, hold revolutionize development delivery, ultimately improving outcomes across various medical fields.

Language: Английский

Citations

1
Exosomes as Nanocarrier for Neurotherapy: Journey from Application to Challenges DOI
Yogita Ale, Nidhi Nainwal

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106312 - 106312

Published: Oct. 1, 2024

Language: Английский

Citations

0